Pfizer agreed to pay $14.5 million to resolve False Claims Act allegations related to its marketing of the drug Detrol. The government alleged Pfizer marketed Detrol for uses that had not been approved by the U.S. Food and Drug Administration (FDA). The settlement resolved the last of a group of whistleblower lawsuits filed in federal courts beginning in 2003. The other suits were settled or dismissed in 2009 as part of global settlement under which Pfizer agreed to pay $2.3 billion dollars to resolve civil and criminal claims regarding the illegal marketing of multiple drugs (see Pfizer instance, “Illegal Marketing of Bextra and Other Drugs”).